Biomarkers for Early Detection of Non-Alcoholic Steatohepatitis: Implications for Drug Development and Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|14|11|1357-1366

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.11, 2013-10, pp. : 1357-1366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis

By Fisher Craig  

Archives of Toxicology, Vol. 82, Iss. 12, 2008-12 ,pp. : 959-964

Springer Publishing Company

Access to resources Recommend Favorite

A New Approach to Drug Therapy in Non-alcoholic Steatohepatitis (NASH)

By Fehér J   Lengyel G  

The Journal of International Medical Research, Vol. 31, Iss. 6, 2003-11 ,pp. : 537-551

Field House Publishing

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic steatohepatitis

By Tomeno Wataru   Yoneda Masato   Imajo Kento   Ogawa Yuji   Kessoku Takaomi   Saito Satoru   Eguchi Yuichiro   Nakajima Atsushi  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. : 279-290

Informa Healthcare

Access to resources Recommend Favorite

Evolving therapies for non-alcoholic steatohepatitis

By Tilg Herbert   Moschen Alexander R  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 6, 2014-06 ,pp. : 687-696

Informa Healthcare

Access to resources Recommend Favorite

Cyclophosphamide/dexamethasone: Non-alcoholic steatohepatitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1233, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite